ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in October 2021. Updated October 31, 2021.
A roundup of FDA’s actions in October 2021.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in October 2021. Updated October 31, 2021.
A roundup of FDA’s actions in October 2021.